Insular cortex is a trait marker for pain processing in fibromyalgia syndrome - Blood oxygenation level-dependent functional magnetic resonance imaging study in Korea

Clinical and Experimental Rheumatology

Volumn 29, Issue 6 SUPPL. 69, 2011, Pages

  Kim, S H ^a,c   Chang, Y ^b   Kim, J H ^b   Song, H J ^b   Seo, J ^b   Han, S W ^d   Nam, E J ^e   Choi, T Y ^f   Lee, S J ^e   Kim, S K ^f  

^a Inje University College of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Keimyung University   (South Korea)

^d Daegu Fatima Hospital   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Catholic University of Daegu   (South Korea)

Author keywords

Blood oxygen level dependent; Fibromyalgia syndrome; Functional magnetic resonance imaging; Insula; Pain

Indexed keywords

ADULT; ARTICLE; BLOOD OXYGENATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INSULA; NAIL BED; NOCICEPTION; OXYGEN BLOOD LEVEL; PAIN; PRESSURE; PRIORITY JOURNAL; SUPERIOR TEMPORAL GYRUS; BLOOD; BRAIN CORTEX; BRAIN MAPPING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; SOMATOSENSORY CORTEX; SYNDROME; TEMPORAL LOBE;

OXYGEN;

ADULT; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FIBROMYALGIA; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN; PAIN; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; PRESSURE; QUESTIONNAIRES; SOMATOSENSORY CORTEX; SYNDROME; TEMPORAL LOBE;

EID: 83655174431     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
2. MALEMUD CI: Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome. Clin Exp Rheumatol 2009;27(Suppl. 56):S86-91.
3. SALAFFI F, SARZI-PUTTINI P, CIAPETTI A, ATZENI F: Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 2009;27(Suppl. 56):S92-105.
4. ARNOLD LM, HUDSON JI, HESS EV et al.: Family study of fibromyalgia. Arthritis Rheum 2004;50:944-52. (Pubitemid 38326195)
5. OFFENBAECHER M, BONDY B, DE JONG S et al.: Possible association of fibromyalgia with a polymorphism in the regulatory region. Arthritis Rheum 1999;42:2482-8. (Pubitemid 30333429)
6. ZUBIETA JK, HEITZEG M, SMITH YR: COMT Val 158 Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;5610:1240-3. (Pubitemid 36237467)
7. CROFFORD U, PILLEMER SR, KALOGERAS KT et al.: Hypothalamicpituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92. (Pubitemid 24345804)
8. MCLEAN SA, WILLIAMS DA, STEIN PK et al.: Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 2006;31:2776-82. (Pubitemid 44764174)
9. WILLIAMS DA, GRACELY RH: Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 2006;8:224.
10. APKARIAN AV, BUSHNELL MC, TREEDE RD, ZUBIETA JK: Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005;9:463-84. (Pubitemid 40836040)
11. MOUNTZ JM, BRADLEY LA, MODELL JG et al.: Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
12. KWIATEK R, BARNDEN LZ, TEDMAN R et al.: Regional cerebral blood flow in fibromyalgia: singlephoton-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43:2823-33. (Pubitemid 32001750)
13. GRACELY RH, PETZKE F, WOLF JM, CLAUW DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-43. (Pubitemid 34525843)
14. COOK DB, LANGE G, CICCONE DS, LIU WC, STEFFENER J, NATELSON BH: Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364-78. (Pubitemid 38160761)
15. HARRIS RE, SUNDGREN PC, PANG Y et al.: Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008;58:903-7. (Pubitemid 351364893)
16. VALDES M, COLLADO A, BARGALLÓ N et al.: Increased glutamate-glutamine compounds (Glx) in the brain of patients with fibromyalgia: A MR spectroscopy study. Arthritis Rheum 2010;62:1829-36.
17. FAYED N, GARCIA-CAMPAYO J, MAGALLÓN R et al.: Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther 2010;12:R134.
18. OKIFUJI A, TURK DC, SINCLAIR JD, STARZ TW, MARCUS DA: A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 1997;24:377-83. (Pubitemid 27104106)
19. KIM YA, LEE SS, PARK K: Validation of a Korean version of the Fibromyalgia Impact Questionnaire. J Korean Med Sci 2002;17:220-4.
20. YUN YH, WANG XS, LEE JS et al.: Validation study of the Korean version of the brief fatigue inventory. J Pain Symptom Manage 2005;29:165-72. (Pubitemid 40279053)
21. JO SA, PARK MH, JO I, RYU SH, HAN C: Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry 2007;22:218-23. (Pubitemid 46431712)
22. YOOK SP, KIM ZS: A clinical study on the Korean version of Beck anxiety inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185-97.
23. GEISSER ME, GLASS JM, RAJCEVSKA LD et al.: A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 2008;9:417-22.
24. EVANS AC, COLLINS DL, MILLS SR, BROWN ED, KELLY RL, PETERS TM: 3D Statistical neuroanatomical models from 305 MRI volumes. In Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference. 1993;3:1813-7.
25. TALAIRACH J, TOURNOUX P: Co-Planar Stereotaxic Atlas of the Human Brain (Thieme, Stuttgart, Germany, 1988).
26. GENOVESE CR, LAZAR NA, NICHOLS T: Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870-8. (Pubitemid 34852500)
27. BRETT M, ANTON JL, VALABREGUE R, POLINE JB: Region of interest analysis using an SPM toolbox [abstract]. Neuroimage 2002;16:S497.
28. FULBRIGHT RK, TROCHE CJ, SKUDLARSKI P, GORE JC, WEXLER BE: Functional MR imaging of regional brain activation associated with the affective experience of pain. Am J Roentgenol 2001;177:1205-10. (Pubitemid 32995570)
29. SCHMIDT-WILCKE T, LUERDING R, WEIGAND et al.: Striatal grey matter increase in patients suffering from fibromyalgia - a voxel-based morphometry study. Pain 2007;132(Suppl. 1):S109-16. (Pubitemid 350030865)
30. GIESECKE T, GRACELY RH, WILLIAMS DA, GEISSER ME, PETZKE FW, CLAUW DJ: The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005;52:1577-84. (Pubitemid 40663950)
31. LUTZ J, JÄGER L, DE QUERVAIN D et al.: White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 2008;58:3960-9.